Compare Equinix Inc (EQIX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs Zimmer Biomet Holdings Inc — how do they compare? Equinix Inc trades at $1,073.78 (market cap $105.50B), while Zimmer Biomet Holdings Inc trades at $99.52 (market cap $18.67B). The key difference: Equinix Inc is far larger — about 5.7× Zimmer Biomet Holdings Inc's market cap, and Equinix Inc pays the higher dividend (1.93%). Which is the better fit depends on your goals.
| EQIX | ZBH | |
|---|---|---|
Market Cap | $105.50B | $18.67B |
Sector | Real Estate | Health |
52-Week High | $1.12K | $107.71 |
52-Week Low | $726.09 | $79.58 |
Enterprise Value | $126.63B | $25.74B |
Dividend Yield | 1.93% | 0.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $1,069.17, up 3.56% with strong institutional support and bullish technical signals. The data center REIT shows robust revenue growth from $9.22B in 2025 to projected $9.8B in 2026, though elevated P/E of 68.8 and recent earnings misses warrant caution. Recent partnerships with All Nippon Airways and infrastructure developments highlight strategic expansion amid AI-driven demand.
Outlook remains positive with 74.5% analyst buy ratings and $1,120 consensus target, but high valuation and negative cash flow trends pose risks. The stock offers dividend stability with $5.16 payouts, yet investors must monitor debt levels rising to 47.1% of assets and capital-intensive growth plans.
Zimmer Biomet (ZBH) trades at $99.57, up 2.41% today, with a bullish technical signal and consistent earnings beats. Revenue grew to $8.23B in 2025, though net income margin declined to 8.56%. The stock is near resistance at $100, with a P/E of 23.76 and analyst consensus target of $103.56. Recent Q2 2026 results showed sales growth of 4.8% and an EPS beat.
Outlook is positive with raised 2026 guidance and strong institutional interest, but risks include margin pressure and high debt. Analysts are mixed with 40% buy ratings, highlighting growth in hips and robotics as key drivers. Investors should monitor execution against targets and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
